Validation of a rapid biomarker assay for lung cancer using the IntelliPlex panel
Abstract A large proportion of non-small-cell lung cancer (NSCLC) patients harbor clinically actionable genomic alterations, detected in general by broad Next-Generation Sequencing (NGS) panels, since it is the gold standard test and strongly recommended by different societies. However, high failure...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2025-07-01
|
| Serija: | Scientific Reports |
| Online pristup: | https://doi.org/10.1038/s41598-025-10585-y |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|